FDA Braces for Work Influx if Food Additive Regulations Tighten

The Food and Drug Administration is preparing for new regulatory submissions as the Trump administration weighs scrapping a decades-long practice of allowing food manufacturers to self-determine the safety of new ingredients brought to market.

Senior FDA officials at a conference in Washington this week acknowledged expanding the agency’s oversight of ingredients could strain resources and create ripple effects beyond the food sector.

The agency is proposing eliminating the “generally recognized as safe,” or GRAS, pathway that allows companies to introduce new substances without notifying FDA so long as they can internally establish evidence the substance is safe for its intended ...